December 14, 2021

Xeljanz and Xeljanz XR Now Indicated for Ankylosing Spondylitis

Read More
December 13, 2021

Zepatier Approved for Use in Pediatric Patients

Read More
December 13, 2021

FDA Approves New Combination Drug for BPH

Read More
December 10, 2021

Kisqali and Kisqali FeMara Co-Pack Approved for Expanded Use

Read More
December 9, 2021

Expanded Indication for Zynrelef in Surgical Pain Relief

Read More
December 8, 2021

Evusheld Authorized to Prevent COVID-19

Read More
December 7, 2021

New Formulation of Baclofen Approved for Multiple Sclerosis

Read More
December 7, 2021

Xaciato Approved to Treat Vaginal Inflammation Caused by Bacteria

Read More
December 6, 2021

Two-Drug COVID-19 Treatment Receives Expanded Authorization

Read More
December 3, 2021

Keytruda Melanoma Indication Expanded to Include Children

Read More
December 2, 2021

Rituxan Granted New Pediatric Indication

Read More
December 2, 2021

New Vaccine Approved to Prevent Hepatitis B

Read More